Addressing the pervasive gaps in knowledge and care delivery to reduce sex-based
disparities and achieve equity is fundamental to the American Heart Association's …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Symptoms of cardiovascular disease drive health care use and are a major contributor to
quality of life. Symptoms are of fundamental significance not only to the diagnosis of …

Peripheral artery disease (PAD) has a huge social and economic burden and is an
important contributor to the global health burden. Sex differences in PAD are apparent, with …

All guidelines worldwide strongly recommend exercise as a pillar of the management of
patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy in this …

Atherosclerosis is the basis of the cardiovascular continuum in peripheral artery disease
(PAD) patients. Limiting functional decline and increasing quality of life are the main …

Several studies have shown that women and racial and ethnic minority patients are at
increased risk of developing lower extremity peripheral artery disease and suffering adverse …

Peripheral artery disease (PAD) is caused by blocked arteries due to atherosclerosis and/or
thrombosis which reduce blood flow to the lower limbs. It results in major morbidity, including …

Abstract Background and Aims Familial hypercholesterolaemia (FH) is a highly prevalent
monogenic disorder characterized by elevated LDL cholesterol (LDL-C) levels and …

Background Significant race and sex disparities exist in the prevalence, diagnosis, and
outcomes of peripheral artery disease (PAD). However, clinical trials evaluating treatments …